Karen L. Smith - Chief Medical Officer at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karen L. Smith since 13 Feb 2025

Holdings reported by Karen L. Smith for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 194,690 $183,009 $0.9400 19 May 2022 Direct
Employee Stock Option (right to buy) 225,000 01 Feb 2023 Direct Common Stock

Transactions reported by Karen L. Smith for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.